| |
Latest 10 SEC filings (by transaction date) for RGNX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 21/24 | Mar 19/24 | Vasista Vittal | Direct Ownership | Employee Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -20,041 | |
Mar 21/24 | Mar 19/24 | Vasista Vittal | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 20,041 | $3.76 |
Mar 18/24 | Mar 14/24 | Mills Kenneth T. | Direct Ownership | Stock Options (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Mar 18/24 | Mar 14/24 | Mills Kenneth T. | Direct Ownership | Common Stock | S - Open market or private sale | -15,000 | $21.86 |
Mar 18/24 | Mar 14/24 | Mills Kenneth T. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | $3.76 |
Mar 7/24 | Mar 5/24 | Pakola Steve | Direct Ownership | Stock Options (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -12,878 | |
Mar 7/24 | Mar 5/24 | Pakola Steve | Direct Ownership | Common Stock | S - Open market or private sale | -12,878 | $28.36 |
Mar 7/24 | Mar 5/24 | Pakola Steve | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 12,878 | $22.25 |
Feb 16/24 | Feb 14/24 | Mills Kenneth T. | Direct Ownership | Stock Options (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Feb 16/24 | Feb 14/24 | Mills Kenneth T. | Direct Ownership | Common Stock | S - Open market or private sale | -10,348 | $16.88 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RGNX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 21/24 | Mar 19/24 | Vasista Vittal | Direct Ownership | Employee Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -20,041 | |
Mar 21/24 | Mar 19/24 | Vasista Vittal | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 20,041 | $3.76 |
Mar 18/24 | Mar 14/24 | Mills Kenneth T. | Direct Ownership | Stock Options (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Mar 18/24 | Mar 14/24 | Mills Kenneth T. | Direct Ownership | Common Stock | S - Open market or private sale | -15,000 | $21.86 |
Mar 18/24 | Mar 14/24 | Mills Kenneth T. | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | $3.76 |
Mar 7/24 | Mar 5/24 | Pakola Steve | Direct Ownership | Stock Options (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -12,878 | |
Mar 7/24 | Mar 5/24 | Pakola Steve | Direct Ownership | Common Stock | S - Open market or private sale | -12,878 | $28.36 |
Mar 7/24 | Mar 5/24 | Pakola Steve | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 12,878 | $22.25 |
Feb 16/24 | Feb 14/24 | Mills Kenneth T. | Direct Ownership | Stock Options (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Feb 16/24 | Feb 14/24 | Mills Kenneth T. | Direct Ownership | Common Stock | S - Open market or private sale | -10,348 | $16.88 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cerevel Therapeutics Hold (OQ:CERE) |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |